Published in Gene Therapy Weekly, September 21st, 1998
Numerous retrovirally-mediated protocols have been used to attempt long-term gene expression in human epidermal keratinocytes in vivo, and for the most part, have had limited success. Most failures are attributed to a failure to target epidermal stem cells, suboptimal grafting conditions, or inactivation of the retroviral vector.
Because keratinocyte grafts are highly attractive recipient cells for gene therapy, L. Levy and a team of researchers from France and the United Kingdom attempted to overcome these...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.